Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin

Biophysical Journal

Volumn 91, Issue 3, 2006, Pages 957-967

  Cordeiro, Yraima ^a   Kraineva, Julia ^b   Suarez, Marisa Carvalho ^a   Tempesta, Anna Gabriella ^a   Kelly, Jeffery W ^c   Silva, Jerson L ^a   Winter, Roland ^b   Foguel, Debora ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b TU DORTMUND UNIVERSITY   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; MONOMER; PREALBUMIN; TETRAMER;

ACIDIFICATION; ARTICLE; ATMOSPHERIC PRESSURE; BETA SHEET; COMPRESSION; DECOMPRESSION; FIBER; HEATING; HYDROSTATIC PRESSURE; INFRARED RADIATION; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; LIGHT SCATTERING; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURE ANALYSIS; WILD TYPE; X RAY CRYSTALLOGRAPHY;

EID: 33746780089     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.085928     Document Type: Article

References (51)

1. Blake, C. C., M. J. Geisow, S. J. Oatley, B. Rerat, and C. Rerat. 1978. Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J. Mol. Biol. 121:339-356.
2. Sousa, M. M., and M. J. Saraiva. 2003. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog. Neurobiol. 71:385-400.
3. Robbins, J., and J. E. Rall. 1960. Proteins associated with the thyroid hormones. Physiol. Rev. 40:415-489.
4. van Jaarsveld, P., W. T. Branch, J. Robbins, F. J. Morgan, Y. Kanda, and R. E. Canfield. 1973. Polymorphism of Rhesus monkey serum prealbumin. Purification and partial structure. J. Biol. Chem. 248:7898-7903.
5. Almeida, M. R., and M. J. Saraiva. 1996. Thyroxine binding to transthyretin (TTR) variants-two variants (TTR Pro 55 and TTR Met 111) with a particularly low binding affinity. Eur. J. Endocrinol. 2:226-230.
6. Westermark, P., K. Sletten, B. Johansson, and G. G. Cornwell. 1990. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl. Acad. Sci. USA. 87:2843-2845.
7. Connors, L. H., A. M. Richardson, R. Theberge, and C. E. Costello. 2000. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid. 7:54-69.
8. Saraiva, M. J. 2001. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 17:493-503.
9. Benson, M. D. 1989. Familial amyloidotic polyneuropathy. Trends Neurosci. 12:88-92.
10. Damas, A. M., and M. J. Saraiva. 2000. TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J. Struct. Biol. 130:290-299.
11. Colon, W., and J. W. Kelly. 1992. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 31:8654-8660.
12. McCutchen, S. L., W. Colon, and J. W. Kelly. 1993. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry. 32:12119-12127.
13. McCutchen, S. L., Z. Lai, G. Miroy, J. W. Kelly, and W. Colon. 1995. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry. 34:13527-13536.
14. Niraula, T. N., K. Haraoka, Y. Ando, H. Li, H. Yamada, and K. Akasaka. 2002. Decreased thermodynamic stability as a crucial factor for familial amyloidotic polyneuropathy. J. Mol. Biol. 320:333-342.
15. Sekijima, Y., R. L. Wiseman, R. L. Matteson, P. Hammarstrom, S. R. Miller, A. R. Sawkar, W. E. Balch, and J. W. Kelly. 2005. The biological and chemical basis for tissue-selective amyloid disease. Cell. 121:73-85.
16. Lashuel, H. A., Z. Lai, and J. W. Kelly. 1998. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry. 37:17851-17864.
17. Zhang, Q., and J. W. Kelly. 2003. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry. 42:8756-8761.
18. Lai, Z., J. McCulloch, H. A. Lashuel, and J. W. Kelly. 1997. Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry. 36:10230-10239.
19. Jiang, X., C. S. Smith, H. M. Petrassi, P. Hammarstrom, J. T. White, J. C. Sacchettini, and J. W. Kelly. 2001. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 40:11442-11452.
20. Hammarstrom, P., Y. Sekijima, J. T. White, R. L. Wiseman, A. Lim, C. E. Costello, K. Altland, F. Garzuly, H. Budka, and J. W. Kelly. 2003. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry. 42:6656-6663.
21. Plaza del Pino, I. M., B. Ibarra-Molero, and J. M. Sanchez-Ruiz. 2000. Lower kinetic limit to protein thermal stability: a proposal regarding protein stability in vivo and its relation with misfolding diseases. Proteins. 40:58-70.
22. Shnyrov, V. L., E. Villar, G. G. Zhadan, J. M. Sanchez-Ruiz, A. Quintas, M. J. Saraiva, and R. M. Brito. 2000. Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin. Biophys. Chem. 88:61-67.
23. Mozhaev, V. V., K. Heremans, J. Frank, B. Masson, and C. Balny. 1996. High pressure effects on protein structure and function. Proteins. 24:81-91.
24. Balny, C., B. Masson, and K. Heremans. 2002. High pressure effects on biological macromolecules: from structural changes to alteration of cellular processes. Biochim. Biophys. Acta. 1595:3-10.
25. Foguel, D., and J. L. Silva. 2004. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies. Biochemistry. 43:11361-11370.
26. Torrent, J., S. Marchal, P. Tortora, R. Lange, and C. Balny. 2004. High pressure, an alternative approach to understand protein misfolding diseases. Cell. Mol. Biol. 50:377-385.
27. Royer, C. A. 2002. Revisiting volume changes in pressure-induced protein unfolding. Biochim. Biophys. Acta. 1595:201-209.
28. Ferrão-Gonzales, A. D., S. O. Souto, J. L. Silva, and D. Foguel. 2000. The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc. Natl. Acad. Sci. USA. 97:6445-6450.
29. Ferrão-Gonzales, A. D., L. Palmieri, M. Valory, J. L. Silva, H. Lashuel, J. W. Kelly, and D. Foguel. 2003. Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease. J. Mol. Biol. 328:963-974.
30. Dirix, C., F. Meersman, C. E. MacPhee, C. M. Dobson, and K. Heremans. 2005. High hydrostatic pressure dissociates early aggregates of TTR105-115, but not the mature amyloid fibrils. J. Mol. Biol. 347:903-909.
31. Cordeiro, Y., J. Kraineva, R. Ravindra, L. M. Lima, M. P. Gomes, D. Foguel, R. Winter, and J. L. Silva. 2004. Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies. J. Biol. Chem. 279:32354-32359.
32. Lai, Z., W. Colon, and J. W. Kelly. 1996. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry. 35:6470-6482.
33. Hammarstrom, P., X. Jiang, A. R. Hurshman, E. T. Powers, and J. W. Kelly. 2002. Sequence-dependent denaturation energetics: a major determinant in amyloid diseases diversity. Proc. Natl. Acad. Sci. USA. 99:16427-16432.
34. Panick, G., R. Malessa, and R. Winter. 1999. Differences between the pressure- and temperature-induced denaturation and aggregation of beta-lactoglobulin A, B, and AB monitored by FT-IR spectroscopy and small-angle x-ray scattering. Biochemistry. 38:6512-6519.
35. Byler, D. M., and H. Susi. 1986. Examination of the secondary structure of proteins by deconvolved FTIR spectra. Biopolymers. 25:469-487.
36. Herberhold, H., S. Marchal, R. Lange, C. H. Scheyhing, R. F. Vogel, and R. Winter. 2003. Characterization of the pressure-induced intermediate and unfolded state of red-shifted green fluorescent protein - a static and kinetic FTIR, UV/VIS and fluorescence spectroscopy study. J. Mol. Biol. 330:1153-1164.
37. Zandomeneghi, G., M. R. Krebs, M. G. McCammon, and M. Fandrich. 2004. FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci. 13:3314-3321.
38. Toniolo, C., and M. Palumbo. 1977. Solid-state infrared absorption spectra and chain arrangement in some synthetic homooligopeptides in the intermolecularly hydrogen-bonded pleated-sheet beta-conformation. Biopolymers. 16:219-224.
39. Krimm, S., and J. Bandekar. 1986. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein Chem. 38:181-364.
40. Hornberg, A., T. Eneqvist, A. Olofsson, E. Lundgren, and A. E. Sauer-Eriksson. 2000. A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J. Mol. Biol. 302:649-669.
41. Cardoso, I., C. S. Goldsbury, S. A. Muller, V. Olivieri, S. Wirtz, A. M. Damas, U. Aebi, and M. J. Saraiva. 2002. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J. Mol. Biol. 317:683-695.
42. Privalov, P. L. 1990. Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 25:281-305.
43. Foguel, D., and J. L. Silva. 1994. Cold denaturation of a repressor-operator complex: the role of entropy in protein-DNA recognition. Proc. Natl. Acad. Sci. USA. 91:8244-8247.
44. Liu, K., H. S. Cho, D. W. Hoyt, T. N. Nguyen, P. Olds, J. W. Kelly, and D. E. Wemmer. 2000. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J. Mol. Biol. 303:555-565.
45. Liu, K., J. W. Kelly, and D. E. Wemmer. 2002. Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin. J. Mol. Biol. 320:821-832.
46. Foguel, D., M. C. Suarez, A. D. Ferrao-Gonzales, T. C. Porto, L. Palmieri, C. M. Einsiedler, L. R. Andrade, H. A. Lashuel, P. T. Lansbury, J. W. Kelly, and J. L. Silva. 2003. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities. Proc. Natl. Acad. Sci. USA. 100:9831-9836.
47. Dzwolak, W., M. Kato, and Y. Tanigushi. 2002. Fourier transform infrared spectroscopy in high-pressure studies on proteins. Biochim. Biophys. Acta. 1595:131-144.
48. Bouchard, M., J. Zurdo, E. J. Nettleton, C. M. Dobson, and C. V. Robinson. 2000. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9:1960-1967.
49. Dwolak, W., R. Ravindra, J. Lendermann, and R. Winter. 2003. Aggregation of bovine insulin probed by DSC/PPC calorimetry and FTIR spectroscopy. Biochemistry. 42:11347-11355.
50. Olofsson, A., J. H. Ippel, S. S. Wijmenga, E. Lundgren, and A. Ohman. 2004. Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy. J. Biol. Chem. 279:5699-5707.
51. Kelly, J. W., W. Colon, Z. Lai, H. A. Lashuel, J. McCulloch, S. L. McCutchen, G. J. Miroy, and S. A. Peterson. 1997. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv. Protein Chem. 50:161-181.